- Home
- Automated
- List of product information
- FELEXIN 250 FOR ORAL SUSPENSION 250 MG/5 ML [SIN09472P]
FELEXIN 250 FOR ORAL SUSPENSION 250 MG/5 ML [SIN09472P]
Active ingredients: FELEXIN 250 FOR ORAL SUSPENSION 250 MG/5 ML
Product Info
FELEXIN 250 FOR ORAL SUSPENSION 250 MG/5 ML
[SIN09472P]
Product information
Active Ingredient and Strength | CEFALEXIN MONOHYDRATE EQV CEFALEXIN - 5,300 MG/100 ML |
Dosage Form | POWDER, FOR SUSPENSION |
Manufacturer and Country | REMEDICA LTD - CYPRUS |
Registration Number | SIN09472P |
Licence Holder | GOLDPLUS UNIVERSAL PTE LTD |
Forensic Classification | PRESCRIPTION ONLY MEDICINES |
Anatomical Therapeutic Chemical (ATC) code | J01DB01 |
Indications
Cefalexin is a semisynthetic cephalosporin antibiotic for oral suspension.
Felexin is indicated in the treatment of the following infections due to susceptible micro-organisms:
Respiratory tract infections
Otitis media
Skin and soft tissue infections
Bone and joint infections
Genito-urinary infections, including acute prostatitis
Dental infections
Dosage and method of administration
Posology
Adults: The adult dosage ranges 1–4 g daily in divided doses; most infections will respond to a dosage of 500 mg every 8 hours. For skin and soft tissue infections, streptococcal pharyngitis, and mild, uncomplicated urinary tract infections, the usual dosage is 250 mg every 6 hours, or 500 mg every 12 hours.
For more severe infections or those caused by less susceptible organisms, larger doses may be needed.
If daily doses of cefalexin greater than 4 g are required, parenteral cephalosporins, in appropriate doses, should be considered.
The elderly and patients with impaired renal function: As for adults. Reduce dosage if renal function is markedly impaired (see ‘Warnings and precautions’ – please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information).
Paediatric Population:
Children: The usual recommended daily dosage for children is 25–50 mg/kg (10–20 mg/lb) in divided doses. For skin and soft tissue infections, streptococcal pharyngitis, and mild, uncomplicated urinary tract infections, the total daily dose may be divided and administered every 12 hours. For most infections the following schedule is suggested:
Children under 1 year: 125 mg 2 times daily.
Children under 1–4 years: 125 mg 3 times daily.
Children 5–12 years: 250 mg 3 times daily.
In severe infections, the dosage may be doubled. The maximum daily dose is 4 g daily. In the therapy of otitis media, clinical studies have shown that a dosage of 75 to 100 mg/kg/day in 4 divided doses is required.
In the treatment of beta-haemolytic streptococcal infections, a therapeutic dose should be administered for at least 10 days.
Method of administration
Oral administration.
Directions for reconstitution:
Check that the bottle’s cap is intact before use. Shake to loosen powder. Add water up to the bottle line, invert the bottle, tap until the powder falls in the water and shake well. Allow the suspension to stand for a few seconds and when the suspension retreats below the bottle line, add more water up to the bottle line and shake again. Shake well before each use.
Contraindications
Felexin is contra-indicated in patients with known allergy to the cephalosporin group of antibiotics.
